Collections / zenodo-19304282

zenodo-19304282

Datasets20
Size~44.4 GB
TechnologyVisium
Samplehuman · pancreas
KindPublication
Flag a data issue
10.1158/2159-8290.cd-25-2001 ↗
Python · sddb client
from sddb import Catalog

cohort = Catalog().collection("zenodo-19304282")
cohort.members        # the 20 datasets as a table

print(cohort.licenses())              # check the terms before you download

sdatas = cohort.to_dict()             # {uid: SpatialData}, cached locally
# or keep the .zarr files in a folder of your choice:
# sdatas = cohort.to_dict(dest="data/")
Python · lamindb

Needs pip install lamindb and network access to the Lamin database, which is limited during the alpha. If it fails, use the Client tab.

import lamindb as ln

db = ln.DB("scverse/spatialdata-db")
coll = db.Collection.get(key="zenodo-19304282")
coll.ordered_artifacts.to_dataframe()   # the 20 members, ordered

# download every member .zarr to the local cache:
paths = [a.cache() for a in coll.ordered_artifacts.all()]
Shell
# sddb client: download every member .zarr into data/
sddb-cli download --collection zenodo-19304282 --dest data/

Licenses: 20 CC BY 4.0

Asynchronous Evolution of Epithelium and Stroma Differentiates Precursor Lesions from Pancreatic Cancer.

Pancreatic intraepithelial neoplasia (PanIN) precedes pancreatic cancer, a deadly disease characterized by an extensive tumor microenvironment. How the microenvironment evolves during cancer progression is largely unknown, as PanINs are microscopic and nondiseased pancreas samples are exceedingly rare, while adjacent normal samples are disrupted by the presence of malignancy. Leveraging donor organs and spatial technologies, we mapped the evolution of PanIN to cancer. The PanIN epithelial component falls on a continuum with cancer, whereas the PanIN microenvironment is drastically distinct. Progression to cancer is accompanied by profound geographic reorganization of myeloid cells and lymphocytes and the formation of a cancer-specific fibroblast population characterized by high levels of smooth muscle actin, LRRC15, and the WNT signaling component LEF1. Together, our data show asynchronous evolution of epithelial and stromal components during pancreatic carcinogenesis. Lack of stromal reprogramming might explain why most PanINs do not progress to cancer. Compiled data available at https://www.pancreas-precancer-atlas.com/.<h4>Significance</h4>Pancreatic cancer precursor lesions are widely prevalent in the population, but progression to invasive cancer is uncommon. Identifying barriers to cancer progression is critical for cancer interception. Our findings describe unique features of the precancer microenvironment that are likely responsible for keeping precursor lesions from progressing to malignancy.

Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Patient_27_SP)
human pancreas 4.6 GB 14,180 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size4.6 GB
Spots14,180
Magnification20x · 0.505 µm/px
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Patient_22_SP_2)
human pancreas 2.5 GB 6,676 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size2.5 GB
Spots6,676
Magnification20x · 0.506 µm/px
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Donor_23_SP1)
human pancreas 1.4 GB 12,692 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size1.4 GB
Spots12,692
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Donor_19_SP)
human pancreas 2.1 GB 12,648 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size2.1 GB
Spots12,648
Magnification20x · 0.506 µm/px
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Donor_9_SP)
human pancreas 3.3 GB 13,486 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size3.3 GB
Spots13,486
Magnification20x · 0.524 µm/px
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Patient_22_SP_1)
human pancreas 2.0 GB 12,906 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size2.0 GB
Spots12,906
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Patient_28_SP)
human pancreas 6.1 GB 13,593 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size6.1 GB
Spots13,593
Magnification20x · 0.523 µm/px
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Donor_22_SP)
human pancreas 1.2 GB 8,470 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size1.2 GB
Spots8,470
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Donor_23_SP2)
human pancreas 1.5 GB 13,720 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size1.5 GB
Spots13,720
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Donor_20_SP)
human pancreas 1.8 GB 11,887 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size1.8 GB
Spots11,887
Magnification20x · 0.523 µm/px
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Donor_3_SP)
human pancreas 2.4 GB 13,972 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size2.4 GB
Spots13,972
Magnification20x · 0.506 µm/px
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Patient_25_SP)
human pancreas 2.9 GB 11,963 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size2.9 GB
Spots11,963
Magnification20x · 0.523 µm/px
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Patient_24_SP)
human pancreas 1.6 GB 14,336 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size1.6 GB
Spots14,336
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Patient_21_SP)
human pancreas 1.6 GB 13,872 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size1.6 GB
Spots13,872
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Donor_25_SP)
human pancreas 1.2 GB 10,250 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size1.2 GB
Spots10,250
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Donor_24_SP)
human pancreas 941 MB 8,329 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size941 MB
Spots8,329
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Patient_23_SP)
human pancreas 1.5 GB 14,336 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size1.5 GB
Spots14,336
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Patient_26_SP)
human pancreas 2.6 GB 13,251 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size2.6 GB
Spots13,251
Magnification20x · 0.506 µm/px
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Donor_21_SP)
human pancreas 1.2 GB 8,796 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size1.2 GB
Spots8,796
silver H&E
Visium
Human pancreas
(Elhossiny et al, Cancer Discovery, 2026) Visium Spatial Transcriptomics Samples (Donor_4_SP)
human pancreas 2.0 GB 11,568 spots silver H&E
TechnologyVisium
Organismhuman
Tissuepancreas
Size2.0 GB
Spots11,568
Magnification20x · 0.506 µm/px
silver H&E

Cite this collection

No linked publication found — please cite the data source.